Evaxion A (EVAX) Cash from Financing Activities (2020 - 2022)
Evaxion A (EVAX) reported Cash from Financing Activities of -$300000.0 for Q2 2022, down 101.19% on a YoY basis from $25.2 million in Q2 2021, and down 103.88% quarter-over-quarter from $7.7 million in Q1 2022.
Evaxion A (EVAX) Cash from Financing Activities (2020 - 2022) Analysis & Trends
Evaxion A has reported Cash from Financing Activities for 3 years, with the latest figure at -$300000.0 in Q2 2022.
- For the quarter ending Q2 2022, Cash from Financing Activities fell 101.19% year-over-year to -$300000.0; the trailing twelve-month figure through Jun 2022 stood at $57.8 million (up 1.64% YoY), and the FY2025 full-year result was $22.4 million, up 70.69% from the prior year.
- Cash from Financing Activities for Q2 2022 stood at -$300000.0, down from $7.7 million in the prior quarter.
- The five-year high for Cash from Financing Activities was $25.3 million in Q1 2021, with the low at -$300000.0 in Q2 2022.
- Historically, Cash from Financing Activities has averaged $11.2 million across 3 years, with a median of $7.1 million in 2020.
- Annual changes were most pronounced in 2021 — Cash from Financing Activities jumped 140388.89% — and 2022, when it plunged 101.19%.
- Evaxion A's Cash from Financing Activities stood at $6.4 million in 2020, then soared by 290.38% to $25.2 million in 2021, then sank by 101.19% to -$300000.0 in 2022.
- The last three Cash from Financing Activities figures came in at -$300000.0 (Q2 2022), $7.7 million (Q1 2022), and $25.2 million (Q3 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 7.00 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -600,000.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 53,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -538.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 85,464.43 |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | -802.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -300,000.00 |
| Jun 30, 2022 | -300,000.00 |
| Mar 31, 2022 | 7.74 Mn |
| Mar 31, 2022 | 7.74 Mn |
| Sep 30, 2021 | 25.15 Mn |
| Sep 30, 2021 | 25.15 Mn |
| Jun 30, 2021 | 25.22 Mn |
| Jun 30, 2021 | 25.22 Mn |
| Mar 31, 2021 | 25.25 Mn |
| Mar 31, 2021 | 25.25 Mn |
| Sep 30, 2020 | 6.44 Mn |
| Sep 30, 2020 | 6.44 Mn |
| Jun 30, 2020 | -36,000.00 |
| Jun 30, 2020 | -36,000.00 |
| Mar 31, 2020 | -18,000.00 |
| Mar 31, 2020 | -18,000.00 |